Cargando…
P-49 COVID 19-PANDEMIC AND OUTCOMES IN DECOMPENSATE CIRRHOSIS-10 MONTHS REVIEW
BACKGROUND AND AIMS: Liver abnormalities are frequent in COVID-19 disease, AST and ALT abnormalities are present in about 60% of serious disease patients. However, liver insufficiency and liver mortality were not important concerns. Decompensate cirrhotic patients are a group of high risk for morbid...
Autores principales: | Pollo-Flores, Priscila, Meyas, Gabriel Alverca, Rodrigues, Vanessa, de Souza, Janaisa Moraes, Cardoso, Pamela Moura Rodrigues, Leitão, Iasmin Torres, Fenizola dos Santos da Silva, Stephanie Cathren, Villar, Lívia Melo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468371/ http://dx.doi.org/10.1016/j.aohep.2021.100413 |
Ejemplares similares
-
Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012) -
Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015) -
COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020) -
Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022) -
Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)